SCHEMBL6992231

SCHEMBL6992231

Oc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCC[C@@H]1CCCO1

nearest known ligand 0.61

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
EGFR P00533 15/20 0.61
KDR P35968 5/20 0.57
EPHA2 P29317 4/20 0.57
EPHB4 P54760 4/20 0.57
FBP1 P09467 2/20 0.54
AURKA O14965 1/20 0.53
ERBB2 P04626 1/20 0.53
INSR P06213 1/20 0.53
PDGFRB P09619 1/20 0.53
FLT4 P35916 1/20 0.53
CLK1 P49759 1/20 0.53
TEK Q02763 1/20 0.53
AURKB Q96GD4 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7226666 0.92 KDR (0.68) EGFRKDREPHA2EPHB4FBP1
SCHEMBL7226668 0.92 KDR (0.68) EGFRKDREPHA2EPHB4FBP1
SCHEMBL6998297 0.88 EGFR (0.70) EGFRKDREPHA2EPHB4FBP1
SCHEMBL7221348 0.88 EGFR (0.70) EGFRKDREPHA2EPHB4FBP1
Hydrochloric Acid SCHEMBL6990351 0.87 KDR (0.60) EGFRKDREPHA2EPHB4FBP1
SCHEMBL6993684 0.83 EGFR (0.63) EGFRKDREPHA2EPHB4FBP1
SCHEMBL6989639 0.83 EPHA2 (0.70) EGFRKDREPHA2EPHB4FBP1
SCHEMBL7221051 0.83 EPHA2 (0.70) EGFRKDREPHA2EPHB4FBP1
SCHEMBL7219862 0.83 EPHA2 (0.70) EGFRKDREPHA2EPHB4FBP1
SCHEMBL7221058 0.83 EPHA2 (0.70) EGFRKDREPHA2EPHB4FBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1315705-A1 BICYCLIC HETEROCYCLES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE, AND METHODS FOR THE PRODUCTION THEREOF BOEHRINGER INGELHEIM ZENTRALE GMBH (DE) 2003-06-04 EP disclosed
WO-2002018351-A1 BICYCLIC HETEROCYCLES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE, AND METHODS FOR THE PRODUCTION THEREOF BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2002-03-07 WO disclosed